Suppr超能文献

相似文献

1
Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs.
AAPS J. 2012 Dec;14(4):703-13. doi: 10.1208/s12248-012-9389-7. Epub 2012 Jul 14.
3
Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
Mol Pharm. 2018 Jun 4;15(6):2355-2371. doi: 10.1021/acs.molpharmaceut.8b00206. Epub 2018 May 4.
5
6
Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.
Pharm Res. 2013 Dec;30(12):2976-92. doi: 10.1007/s11095-013-1126-0. Epub 2013 Jul 4.
7
Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs.
Expert Opin Drug Metab Toxicol. 2021 May;17(5):555-580. doi: 10.1080/17425255.2021.1902986. Epub 2021 Apr 8.
10
Supersaturated polymeric micelles for oral cyclosporine A delivery.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1325-36. doi: 10.1016/j.ejpb.2013.08.003. Epub 2013 Aug 13.

引用本文的文献

2
Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation.
Mol Pharm. 2025 Mar 3;22(3):1396-1407. doi: 10.1021/acs.molpharmaceut.4c01102. Epub 2025 Feb 20.
3
Superporous hydrogels based on blends of chitosan and polyvinyl alcohol as a carrier for enhanced gastric delivery of resveratrol.
Saudi Pharm J. 2023 Mar;31(3):335-347. doi: 10.1016/j.jsps.2023.01.001. Epub 2023 Jan 5.
5
Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.
Mol Pharm. 2023 Mar 6;20(3):1681-1695. doi: 10.1021/acs.molpharmaceut.2c00895. Epub 2023 Feb 2.
7
Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.
AAPS PharmSciTech. 2022 Sep 2;23(7):249. doi: 10.1208/s12249-022-02408-4.
10
The function of oxybuprocaine: a effect that sustains the supersaturated state of anhydrous piroxicam crystals.
RSC Adv. 2020 Jan 8;10(3):1572-1579. doi: 10.1039/c9ra09952b. eCollection 2020 Jan 7.

本文引用的文献

1
Assessing the performance of amorphous solid dispersions.
J Pharm Sci. 2012 Apr;101(4):1355-77. doi: 10.1002/jps.23031. Epub 2011 Dec 27.
3
Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
Drug Dev Ind Pharm. 2012 May;38(5):557-70. doi: 10.3109/03639045.2011.616513. Epub 2011 Oct 1.
4
Dissolution and precipitation behavior of amorphous solid dispersions.
J Pharm Sci. 2011 Aug;100(8):3316-3331. doi: 10.1002/jps.22579. Epub 2011 May 23.
5
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Int J Pharm. 2011 May 16;409(1-2):260-8. doi: 10.1016/j.ijpharm.2011.02.051. Epub 2011 Mar 1.
6
Excipient-mediated supersaturation stabilization in human intestinal fluids.
Mol Pharm. 2011 Apr 4;8(2):564-70. doi: 10.1021/mp100377m. Epub 2011 Feb 22.
8
Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion.
Drug Dev Ind Pharm. 2011 Jun;37(6):694-701. doi: 10.3109/03639045.2010.535822. Epub 2011 Jan 13.
9
Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.
J Drug Target. 2010 Dec;18(10):704-31. doi: 10.3109/1061186X.2010.525652. Epub 2010 Oct 26.
10
Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.
Eur J Pharm Sci. 2010 Dec 23;41(5):623-30. doi: 10.1016/j.ejps.2010.09.002. Epub 2010 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验